Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01938651 · ClinicalTrials.gov registry record · NA
Ultra High Field MRI and MRS Techniques in Diagnosing Breast Cancer
A NA study, sponsored by Vanderbilt-Ingram Cancer Center.
- Terminated
- Registry status
- NA
- Development phase
- 3
- Enrollment target
NCT01938651 is a NA study that was terminated before completion, run by Vanderbilt-Ingram Cancer Center. The registered enrollment target is 3 participants.
The verdict
NCT01938651, a NA study, was terminated before completion, sponsored by Vanderbilt-Ingram Cancer Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
Study Summary
This pilot clinical trial studies ultra-high field magnetic resonance imaging (MRI) and magnetic resonance spectroscopy (MRS) techniques in diagnosing breast cancer. New diagnostic procedures may be a more sensitive way to detect breast cancer.
Interventions
- PROCEDURE diffusion-weighted magnetic resonance imaging
- PROCEDURE dynamic contrast-enhanced magnetic resonance imaging
- PROCEDURE magnetic resonance spectroscopic imaging
- PROCEDURE high field strength magnetic resonance imaging
- PROCEDURE chemical exchange saturation transfer magnetic resonance imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2013-01 |
| Est. Completion | 2015-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01938651
The ClinicalTrials.gov registry entry for NCT01938651 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt-Ingram Cancer Center, which has 189 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which diffusion-weighted magnetic resonance imaging is the first listed.
NCT01938651 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01938651 about?
NCT01938651 is a clinical study titled "Ultra High Field MRI and MRS Techniques in Diagnosing Breast Cancer". This pilot clinical trial studies ultra-high field magnetic resonance imaging (MRI) and magnetic resonance spectroscopy (MRS) techniques in diagnosing breast cancer. New diagnostic procedures may be a more sensitive way to detect breast cancer.
What is the current status of trial NCT01938651?
This trial is currently terminated. It is a NA study. The enrollment target is 3 participants. The study started on 2013-01. Estimated completion is 2015-06.
What interventions are being tested in trial NCT01938651?
The interventions under investigation include: diffusion-weighted magnetic resonance imaging (PROCEDURE), dynamic contrast-enhanced magnetic resonance imaging (PROCEDURE), magnetic resonance spectroscopic imaging (PROCEDURE), high field strength magnetic resonance imaging (PROCEDURE), chemical exchange saturation transfer magnetic resonance imaging (PROCEDURE).
Who is sponsoring clinical trial NCT01938651?
This trial is sponsored by Vanderbilt-Ingram Cancer Center, which has 189 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.